General Information of the Protein
Protein ID |
PT04413
|
||||
---|---|---|---|---|---|
Protein Name |
Vitamin K epoxide reductase complex subunit 1
|
||||
Secondarily Protein Name |
Vitamin K1 2,3-epoxide reductase subunit 1
|
||||
Gene Name |
VKORC1
|
||||
Secondarily Gene Name |
VKOR
MSTP134
MSTP576
UNQ308/PRO351
|
||||
Sequence |
MGSTWGSPGWVRLALCLTGLVLSLYALHVKAARARDRDYRALCDVGTAISCSRVFSSRWGRGFGLVEHVLGQDSILNQSNSIFGCIFYTLQLLLGCLRTRWASVLMLLSSLVSLAGSVYLAWILFFVLYDFCIVCITTYAINVSLMWLSFRKVQEPQGKAKRH
Show/Hide
|
||||
Organism |
Homo sapiens, Human
|
||||
Protein Classification |
Enzyme
>
Oxidoreductase
|
||||
Function |
Involved in vitamin K metabolism. Catalytic subunit of the vitamin K epoxide reductase (VKOR) complex which reduces inactive vitamin K 2,3-epoxide to active vitamin K. Vitamin K is required for the gamma-carboxylation of various proteins, including clotting factors, and is required for normal blood coagulation, but also for normal bone development.
Show/Hide
|
||||
Uniprot ID |
Show/Hide
|
||||
Ensembl ID | |||||
HGNC ID | |||||
Subcellular Location |
Endoplasmic reticulum membrane
|
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein Protein Cell Line Compound Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000006 , HEK293
Clinical Information about the Protein
Target 1 ( Vitamin K epoxide reductase complex 1 (VKORC1) )
Target Type | Successful Target | ||||
---|---|---|---|---|---|
Disease | 3 Target-related Diseases | 3 | |||
1 | Thrombosis [ICD-11: DB61-GB90] | ||||
2 | Coagulation defect [ICD-11: 3B10.0] | ||||
3 | Atrial fibrillation [ICD-11: BC81.3] | ||||
Approved Drug(s) | 5 Approved Drugs | 5 | |||
1 | Acenocoumarol | Approved | |||
2 | Dicumarol | Approved | |||
3 | Phenindione | Approved | |||
4 | Phenprocoumon | Approved | |||
5 | Warfarin | Approved |